Dementia with Lewy bodies (DLB), Parkinson's disease (PD) and multiple system atrophy are characterized by the deposition of disease-associated α-synuclein. In the present study we 1) examined the molecular specificity of the novel anti-α-synuclein 5G4 antibody; 2) evaluated immunoreactivity patterns and their correlation in human brain tissue with micro-and astrogliosis in 57 cases with PD or DLB; and 3) performed a systematic immunoelectron microscopical mapping of subcellular localizations. 5G4 strongly binds to the high molecular weight fraction of β-sheet rich oligomers, while no binding to primarily disordered oligomers or monomers was observed. We show novel localizations of disease-associated α-synuclein including perivascular macrophages, ependyma and cranial nerves. α-Synuclein immunoreactive neuropil dots and thin threads associate more with glial reaction than Lewy bodies alone. Astrocytic α-synuclein is an important component of the pathology. Furthermore, we document ultrastructurally the pathway of processing of disease-associated α-synuclein within neurons and astroglial cells. Interaction of mitochondria and disease-associated α-synuclein plays a key role in the molecular-structural cytopathogenesis of disorders with Lewy bodies. We conclude that 1) the 5G4 antibody has strong selectivity for β-sheet rich α-synuclein oligomers; 2) Lewy bodies themselves are not the most relevant morphological substrate that evokes tissue lesioning; 3) both neurons and astrocytes internalize disease-associated α-synuclein in the human brain, suggesting prion-like cell-to-cell spread of α-synuclein by uptake from surrounding structures, as shown previously in experimental observations. © 2014 Elsevier Inc. All rights reserved.
Introduction α-Synuclein is a 140 amino acid protein that is physiologically found mainly in a presynaptic location (Iwai et al., 1995) . It belongs to the class of intrinsically unstructured proteins and it is characterized by a remarkable conformational plasticity (Uversky, 2003) . Indeed, it may stay unfolded, or adopt an amyloidogenic partially folded conformation, or fold into α-helical or β-structural species, both monomeric and oligomeric (Uversky, 2003) . In addition to the formation of oligomers, biochemical modifications like nitration and phosphorylation occur (Kovacs et al., 2010) . A major role of α-synuclein was suggested for a group of neurodegenerative diseases called α-synucleinopathies. These include disorders that show mainly neuron-related accumulation of α-synuclein, like Parkinson`s disease (PD) and Dementia with Lewy bodies (DLB), while multiple system atrophy (MSA) is a disease characterized mainly by oligodendroglial cytoplasmic inclusions (Jellinger, 2012) . PD and DLB share common morphological features described as Lewy bodies and Lewy neurites. Recent advances in immunohistochemistry revealed that dot-like structures and thin neurites are also present in the brains of patients with PD and DLB, which are likely better substrates for the clinical symptoms (Alafuzoff et al., 2008b (Alafuzoff et al., , 2009 Leverenz et al., 2008) . However, the currently commercially available anti-α-synuclein antibodies detect also the monomeric physiological form in addition to the pathological inclusions of α-synucleinopathies 
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